Gilead Sciences IncNASDAQ
Historical Stock Data
|52 Week High|
|52 Week Low|
What Are Analysts Recommending for Johnson & Johnson and Gilead?
Johnson & Johnson (JNJ) is up by 10.10%, and Gilead Sciences (GILD) is up by 10.92% on a YTD basis. Both the companies are struggling due to intense competitive pressures either from branded or generic competitors. The consensus recommendation for both Johnson & Johnson and Gilead Sciences is a “buy.”